発血後再注射中のカルシウム投与が心筋の収縮性,硬さ,腫れ,超構造に及ぼす影響
T J Bixler1, J T Flaherty, T J Gardner
1Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Circulation
|September 1, 1978
まとめ
心停止後にカルシウムを投与すると,心臓の機能が改善され,さらなる損傷を引き起こすことなく腫れが軽減されます. この発見は,再注射療法中の心筋細胞の保護を理解するために極めて重要です.
科学分野:
- 心臓病学 心臓病学
- 細胞生物学 細胞生物学
- バイオケミストリー バイオケミストリー
背景:
- 発血後および再注射後の心筋細胞損傷におけるカルシウムの役割は,現在調査中です.
- 低熱性血栓停止は,心機能障害と細胞損傷につながる可能性があります.
研究 の 目的:
- カルシウム投与が心筋収縮性および低熱性缺血性停止および再注血後の損傷に及ぼす影響を調査する.
- カルシウムの潜在力を評価し,心臓の手続きで使用されるシトラートベースの溶液の悪影響を軽減する.
主な方法:
- 血液に浸透したイソヴォルミックの犬の心臓製剤 (n=26) を利用した.
- 犬を4つのグループに分けました. ノルモカルセミックコントロール,カルシウム塩化物 (CaCl2) 投与,チラート・フォスファート・デクストロース (CPD) 投与,CPDとCaCl2の併用投与.
- 左心室の収縮性,心筋の硬さ,細胞/亜細胞損傷,および再注血後の心筋腫を評価した.
主要な成果:
- カルシウム投与 (IIグループ) は,左心室の収縮性を改善し,心臓筋の硬さを増加させたが,対照群 (Iグループ) に比べて追加の細胞損傷を引き起こさなかった.
- サイトレート (CPD) の投与 (III グループ) は収縮性を低下させ,心筋腫を増加させた.
- カルシウムとシトレートの併用投与 (グループIV) は,シトレート誘発の収縮性低下を逆転させ,腫れを最小限に抑え,硬さを増加させ,追加の形態学的損傷を及ぼさなかった.
結論:
- 再注入から15分後に投与されたカルシウムは,低熱性血栓停止後の心臓の収縮性を改善します.
- カルシウム投与は,シトレートの悪影響を相殺し,心臓のケアに潜在的な利点を提供することができます.
- カルシウムは,心筋梗塞の損傷を悪化させることなく,心臓機能の改善のための安全な治療薬であるようです.
関連する概念動画
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...


